Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Certara ( (CERT) ) has shared an announcement.
On March 5, 2025, Certara, Inc. announced that Dr. Patrick F. Smith, who served as President of Certara Drug Development Solutions, stepped down from his role on March 3, 2025. Despite this change, Dr. Smith will continue to contribute to the company in a senior advisory and scientific capacity, indicating a strategic shift in his responsibilities while maintaining his involvement with Certara.
More about Certara
YTD Price Performance: 11.16%
Average Trading Volume: 1,317,871
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.91B
For detailed information about CERT stock, go to TipRanks’ Stock Analysis page.